123 related articles for article (PubMed ID: 36605574)
1. Peptide-RNA complexation-induced fluorescence "turn on" displacement assay for the recognition of small ligands targeting HIV-1 RNA.
Qi L; Zhang J; Gao Y; Gong P; Liang C; Su Y; Zeng Q; Zhang Y
J Pharm Anal; 2022 Dec; 12(6):923-928. PubMed ID: 36605574
[TBL] [Abstract][Full Text] [Related]
2. A ratiometric fluorescence RRE RNA-targeted assay for a new fluorescence ligand.
Qi L; Wei JR; Lv XJ; Huo Y; Zhang ZQ
Biosens Bioelectron; 2016 Dec; 86():287-292. PubMed ID: 27387258
[TBL] [Abstract][Full Text] [Related]
3. Fluorescence-based methods for evaluating the RNA affinity and specificity of HIV-1 Rev-RRE inhibitors.
Luedtke NW; Tor Y
Biopolymers; 2003 Sep; 70(1):103-19. PubMed ID: 12925996
[TBL] [Abstract][Full Text] [Related]
4. Proflavine acts as a Rev inhibitor by targeting the high-affinity Rev binding site of the Rev responsive element of HIV-1.
DeJong ES; Chang CE; Gilson MK; Marino JP
Biochemistry; 2003 Jul; 42(26):8035-46. PubMed ID: 12834355
[TBL] [Abstract][Full Text] [Related]
5. A reporter based single step assay for evaluation of inhibitors targeting HIV-1 Rev-RRE interaction.
Raina S; Chande AG; Baba M; Mukhopadhyaya R
Virusdisease; 2014 Jan; 25(1):101-6. PubMed ID: 24426316
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of neomycin and Rev peptide binding to the Rev responsive element of HIV-1 as determined by fluorescence and NMR spectroscopy.
Lacourciere KA; Stivers JT; Marino JP
Biochemistry; 2000 May; 39(19):5630-41. PubMed ID: 10801313
[TBL] [Abstract][Full Text] [Related]
7. Structural dynamics of HIV-1 Rev and its complexes with RRE and 5S RNA.
Lam WC; Seifert JM; Amberger F; Graf C; Auer M; Millar DP
Biochemistry; 1998 Feb; 37(7):1800-9. PubMed ID: 9485305
[TBL] [Abstract][Full Text] [Related]
8. RNA-ligand interactions: affinity and specificity of aminoglycoside dimers and acridine conjugates to the HIV-1 Rev response element.
Luedtke NW; Liu Q; Tor Y
Biochemistry; 2003 Oct; 42(39):11391-403. PubMed ID: 14516190
[TBL] [Abstract][Full Text] [Related]
9. Quantum-dot-based nanosensor for RRE IIB RNA-Rev peptide interaction assay.
Zhang CY; Johnson LW
J Am Chem Soc; 2006 Apr; 128(16):5324-5. PubMed ID: 16620087
[TBL] [Abstract][Full Text] [Related]
10. A non-canonical base pair within the human immunodeficiency virus rev-responsive element is involved in both rev and small molecule recognition.
Werstuck G; Zapp ML; Green MR
Chem Biol; 1996 Feb; 3(2):129-37. PubMed ID: 8807838
[TBL] [Abstract][Full Text] [Related]
11. Specificity of RSG-1.2 peptide binding to RRE-IIB RNA element of HIV-1 over Rev peptide is mainly enthalpic in origin.
Kumar S; Bose D; Suryawanshi H; Sabharwal H; Mapa K; Maiti S
PLoS One; 2011; 6(8):e23300. PubMed ID: 21853108
[TBL] [Abstract][Full Text] [Related]
12. HIV-1 regulator of virion expression (Rev) protein binds to an RNA stem-loop structure located within the Rev response element region.
Heaphy S; Dingwall C; Ernberg I; Gait MJ; Green SM; Karn J; Lowe AD; Singh M; Skinner MA
Cell; 1990 Feb; 60(4):685-93. PubMed ID: 1689218
[TBL] [Abstract][Full Text] [Related]
13. Water, shape recognition, salt bridges, and cation-pi interactions differentiate peptide recognition of the HIV rev-responsive element.
Michael LA; Chenault JA; Miller BR; Knolhoff AM; Nagan MC
J Mol Biol; 2009 Sep; 392(3):774-86. PubMed ID: 19631217
[TBL] [Abstract][Full Text] [Related]
14. Amino acid requirement for the high affinity binding of a selected arginine-rich peptide with the HIV Rev-response element RNA.
Sugaya M; Nishino N; Katoh A; Harada K
J Pept Sci; 2008 Aug; 14(8):924-35. PubMed ID: 18351707
[TBL] [Abstract][Full Text] [Related]
15. Structure of the HIV-1 Rev response element alone and in complex with regulator of virion (Rev) studied by atomic force microscopy.
Pallesen J; Dong M; Besenbacher F; Kjems J
FEBS J; 2009 Aug; 276(15):4223-32. PubMed ID: 19583776
[TBL] [Abstract][Full Text] [Related]
16. Exchange of the basic domain of human immunodeficiency virus type 1 Rev for a polyarginine stretch expands the RNA binding specificity, and a minimal arginine cluster is required for optimal RRE RNA binding affinity, nuclear accumulation, and trans-activation.
Nam YS; Petrovic A; Jeong KS; Venkatesan S
J Virol; 2001 Mar; 75(6):2957-71. PubMed ID: 11222721
[TBL] [Abstract][Full Text] [Related]
17. Quantifying RNA-peptide interaction by single-quantum dot-based nanosensor: an approach for drug screening.
Zhang CY; Johnson LW
Anal Chem; 2007 Oct; 79(20):7775-81. PubMed ID: 17877365
[TBL] [Abstract][Full Text] [Related]
18. A DEAD-box protein acts through RNA to promote HIV-1 Rev-RRE assembly.
Lamichhane R; Hammond JA; Pauszek RF; Anderson RM; Pedron I; van der Schans E; Williamson JR; Millar DP
Nucleic Acids Res; 2017 May; 45(8):4632-4641. PubMed ID: 28379444
[TBL] [Abstract][Full Text] [Related]
19. Stereospecificity of short Rev-derived peptide interactions with RRE IIB RNA.
Litovchick A; Rando RR
RNA; 2003 Aug; 9(8):937-48. PubMed ID: 12869705
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the EIAV Rev-responsive element (RRE) reveals a conserved RNA motif required for high affinity Rev binding in both HIV-1 and EIAV.
Lee JH; Culver G; Carpenter S; Dobbs D
PLoS One; 2008 Jun; 3(6):e2272. PubMed ID: 18523581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
